Please Note: This trial is no longer enrolling new participants
A RANDOMIZED PHASE II TRIAL OF TAMOXIFEN VERSUS Z-ENDOXIFEN HCL IN POSTMENOPAUSAL WOMEN WITH METASTATIC ESTROGEN RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER
| Protocol No. | A011203 | Scope | National |
|---|---|---|---|
| Principal Investigator | Kathy Miller | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
